Wednesday, June 13, 2007


Chinese authorities investigate sale of fake blood protein to hospitals

‘China said Monday it was investigating the sale of fake blood protein, a potentially dangerous and widespread practice that underscores the country’s problems with product safety.

State media reported one death from use of the counterfeits, but authorities have not said whether anyone has fallen ill.

A shortage of albumin, a blood protein that chronically ill people often lack, triggered a countrywide investigation in March into whether fakes were being sold, China Central Television said.

The report centred on an inquiry in the northeastern province of Jilin, where 59 hospitals and pharmacies were sold more than 2,000 bottles of counterfeit blood protein. It did not say what the products were made of, but said they could “make a patient’s condition worsen and could cause death.”‘

Leave a Reply